WO2004108947A3 - Biological terrain management - Google Patents

Biological terrain management Download PDF

Info

Publication number
WO2004108947A3
WO2004108947A3 PCT/US2004/017316 US2004017316W WO2004108947A3 WO 2004108947 A3 WO2004108947 A3 WO 2004108947A3 US 2004017316 W US2004017316 W US 2004017316W WO 2004108947 A3 WO2004108947 A3 WO 2004108947A3
Authority
WO
WIPO (PCT)
Prior art keywords
identified
values
sample
patient
combination
Prior art date
Application number
PCT/US2004/017316
Other languages
French (fr)
Other versions
WO2004108947A2 (en
Inventor
Timothy Nicholas Ray
Original Assignee
Bioray Inc
Timothy Nicholas Ray
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioray Inc, Timothy Nicholas Ray filed Critical Bioray Inc
Publication of WO2004108947A2 publication Critical patent/WO2004108947A2/en
Publication of WO2004108947A3 publication Critical patent/WO2004108947A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4854—Diagnosis based on concepts of traditional oriental medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/007—Devices for taking samples of body liquids for taking urine samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4538—Evaluating a particular part of the muscoloskeletal system or a particular medical condition
    • A61B5/4542—Evaluating the mouth, e.g. the jaw
    • A61B5/4547—Evaluating teeth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention is directed to a method of balancing structure and function in the human terrain. A sample of urine and a sample of saliva is taken from a patient. The properties for each of the samples are identified. A plurality of zones are provided, each of the zones defining a combination of values and a recommended treatment based on the combination of values. Sample values for the patient are calculated based on the identified properties. One of the zones having the combination of values is identified that correspond to the sample values. The recommended treatment for the patient is then identified based on the identified zone.
PCT/US2004/017316 2003-06-02 2004-06-02 Biological terrain management WO2004108947A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47459303P 2003-06-02 2003-06-02
US60/474,593 2003-06-02

Publications (2)

Publication Number Publication Date
WO2004108947A2 WO2004108947A2 (en) 2004-12-16
WO2004108947A3 true WO2004108947A3 (en) 2006-04-13

Family

ID=33511615

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/017316 WO2004108947A2 (en) 2003-06-02 2004-06-02 Biological terrain management

Country Status (1)

Country Link
WO (1) WO2004108947A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108841476A (en) * 2018-06-22 2018-11-20 江南大学 A kind of fermented type fragrance of a flower pear wine and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6152887A (en) * 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis
US20010023324A1 (en) * 1997-11-03 2001-09-20 Allan Pronovost Glucose detector and method for diagnosing diabetes
US20040122790A1 (en) * 2002-12-18 2004-06-24 Walker Matthew J. Computer-assisted data processing system and method incorporating automated learning
US6835545B2 (en) * 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010023324A1 (en) * 1997-11-03 2001-09-20 Allan Pronovost Glucose detector and method for diagnosing diabetes
US6152887A (en) * 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis
US6835545B2 (en) * 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
US20040122790A1 (en) * 2002-12-18 2004-06-24 Walker Matthew J. Computer-assisted data processing system and method incorporating automated learning

Also Published As

Publication number Publication date
WO2004108947A2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
WO2005062770A3 (en) Method for conducting pharmacogenomics-based studies
WO2002056022A3 (en) Diagnostics, drug screening and treatment for cancer
WO2003090695A3 (en) TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
DE60314500D1 (en) DIAMINOPYRIMIDINE AND ITS USE AS ANGIOGENESEHEMMER
WO2004113275A3 (en) Methods and compositions for treating amyloid-related diseases
WO2006092668A3 (en) Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
WO2004090539A3 (en) Methods of determining efficacy of treatments of inflammatory diseases of the bowel
WO2004047760A3 (en) Novel chemical compounds
WO2003057916A3 (en) Cancer profiles
BRPI0307673A2 (en) methods of treating vascular disease.
AU2003233451A1 (en) Targets, methods, and reagents for diagnosis and treatment of schizophrenia
TW200528117A (en) Methods and reagents for the treatment of proliferative diseases
WO2002058638A3 (en) Serpin drugs for treatment of hiv infection and method of use thereof
WO2004032882A3 (en) Chemical compounds
WO2004033666A3 (en) Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
AU2003291536A1 (en) Method for the diagnosis and treatment of vascular disease
AU2002219137A1 (en) Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
WO2004045376A3 (en) Screening methods to identify treatments for autoimmune disease
WO2004113574A3 (en) Methods for disease screening
WO2004108947A3 (en) Biological terrain management
WO2004005540A3 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
WO2006053252A3 (en) Methods of treating hematological malignancies with nucleoside analog drugs
FI20031678A0 (en) Method and arrangement of sample treatment
WO2003028536A3 (en) Methods for diagnosing and treating heart disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase